From early-stage strategy through commercial partnerships, we bring operator-level insight to every engagement — whether you're a pre-startup, a stalled venture needing to pivot, or an established corporation seeking inorganic growth.
Who We Work With
When you're on the outside looking in, the pharmaceutical industry is daunting in its commercial and regulatory complexity. We help navigate equity investment decisions, establish clear strategic milestones for new drug development, and provide in/out-licensing business development through our offices in Korea, China and Canada.
Capabilities
Small differences in product features and the right commercial partners make all the difference between a successful IVD company and a failed one. We bring first-hand experience establishing and executing commercial strategy in startup environments.
Capabilities
Properly developed nutraceutical ingredients can dramatically increase value, but this requires robust safety and functional proof backed by clinical evidence. We map strategic development pathways through our Seoul-based affiliate TKL Corporation.
Capabilities
Working with health and science government offices to shape healthcare industry policy, build regulatory frameworks, and develop endogenous capacity for pharmaceutical, vaccine and IVD R&D and production.
Capabilities
Strategic execution advisory, B2B matchmaking for joint ventures, licensing and distribution agreements, and corporate transaction advisory for healthcare companies at every stage.
Capabilities
Strategic Network
M&M Pharma — Warsaw, Poland
EU, Russia-CIS and MENA markets since 2019
Market Access Africa — Geneva, Switzerland
African market access since 2023